ES8800936A1 - Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona - Google Patents

Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona

Info

Publication number
ES8800936A1
ES8800936A1 ES554431A ES554431A ES8800936A1 ES 8800936 A1 ES8800936 A1 ES 8800936A1 ES 554431 A ES554431 A ES 554431A ES 554431 A ES554431 A ES 554431A ES 8800936 A1 ES8800936 A1 ES 8800936A1
Authority
ES
Spain
Prior art keywords
group
lower alkylene
tricyclic pyridone
pyridone derivatives
tricyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554431A
Other languages
English (en)
Other versions
ES554431A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES8800936A1 publication Critical patent/ES8800936A1/es
Publication of ES554431A0 publication Critical patent/ES554431A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE BI- Y TRICICLICOS DE PIRIDONA. CONSISTENTE EN HIDROGENAR UN COMPUESTO DE FORMULA (I), EN QUE Q1 Y EL ATOMO DE NITROGENO FORMAN EL GRUPO FN-CHFCH-, PARA OBTENER Y CONVERTIR EL RESULTANTE EN UNA SAL DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLE. SIENDO: RA, FENILO, TIENILO Y OTROS; RB Y RC, ALCOXI, NITRO Y OTROS; RD, -(A1)M-(CO)N-(A2Q2)Q-R1; M, N Y Q, 0 O 1; A1, ALQUILENO INFERIOR; A2, ALQUILENO INFERIOR, ENLACE DIRECTO Y OTROS; Q2, ATOMO DE OXIGENO O GRUPO -NR2; R1, H, CIANO Y OTROS; R2, H, ARILO Y OTROS. SE UTILIZA COMO FARMACO ANTICONVULSIVO.
ES554431A 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona Expired ES8800936A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH530484 1984-11-06
CH383685 1985-09-05

Publications (2)

Publication Number Publication Date
ES8800936A1 true ES8800936A1 (es) 1987-12-01
ES554431A0 ES554431A0 (es) 1987-12-01

Family

ID=25693960

Family Applications (8)

Application Number Title Priority Date Filing Date
ES548532A Expired ES8705436A1 (es) 1984-11-06 1985-11-05 Un procedimiento para la obtencion de derivados de bi- y triciclicosdde piridona
ES554432A Expired ES8800937A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554426A Expired ES8800932A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554430A Expired ES8800939A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554429A Expired ES8800935A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554427A Expired ES8800933A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554431A Expired ES8800936A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554428A Expired ES8800934A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona

Family Applications Before (6)

Application Number Title Priority Date Filing Date
ES548532A Expired ES8705436A1 (es) 1984-11-06 1985-11-05 Un procedimiento para la obtencion de derivados de bi- y triciclicosdde piridona
ES554432A Expired ES8800937A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554426A Expired ES8800932A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554430A Expired ES8800939A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554429A Expired ES8800935A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ES554427A Expired ES8800933A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES554428A Expired ES8800934A1 (es) 1984-11-06 1986-04-28 Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona

Country Status (23)

Country Link
US (2) US4735940A (es)
EP (2) EP0183994B1 (es)
JP (1) JPH0692405B2 (es)
CN (1) CN1016871B (es)
AR (1) AR242579A1 (es)
AT (1) ATE51232T1 (es)
AU (1) AU584132B2 (es)
CA (1) CA1277659C (es)
DE (2) DE3576691D1 (es)
DK (1) DK507685A (es)
DO (1) DOP1985004378A (es)
ES (8) ES8705436A1 (es)
FI (1) FI89049C (es)
GB (1) GB2169288B (es)
HU (1) HU205353B (es)
IE (1) IE58850B1 (es)
IL (1) IL76894A (es)
IS (1) IS1469B6 (es)
MC (1) MC1707A1 (es)
MY (1) MY103172A (es)
NO (1) NO171914C (es)
PT (1) PT81431B (es)
ZW (1) ZW17385A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889848A (en) * 1984-11-06 1989-12-26 Hoffmann-La Roche Inc. Tricyclic pyridine derivatives
NO162285C (no) * 1984-11-23 1989-12-06 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
CA1317945C (en) * 1985-12-13 1993-05-18 Ulf Fischer Tricyclic pyridazopyridone derivatives
EP0294599A3 (de) * 1987-06-12 1990-05-09 F. Hoffmann-La Roche Ag Tricyclische Pyridonderivate
ATE145208T1 (de) * 1990-07-06 1996-11-15 Yoshitomi Pharmaceutical Kondensierte thiophenverbindungen und deren verwendung
CA2058640A1 (en) * 1991-01-25 1992-07-26 Richard R. Scherschlicht Tricyclic pyridone derivative
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
FR2689129B1 (fr) * 1992-03-27 1995-05-12 Atochem Elf Sa Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation.
EP0650966A1 (de) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
US5869500A (en) * 1996-12-13 1999-02-09 Hoffmann-La Roche Inc. Pyridone compounds useful in treating Alzheimer's disease
GB9708945D0 (en) * 1997-05-01 1997-06-25 Merck Sharp & Dohme Therapeutic agents
GB0119828D0 (en) * 2001-08-14 2001-10-10 Merck Sharp & Dohme Therapeutic agents
GB0119803D0 (en) * 2001-08-14 2001-10-10 Merck Sharp & Dohme Therapeutic agents
ATE533782T1 (de) 2006-01-13 2011-12-15 Univ Pennsylvania Impfstoffe und immuntherapeutika mit codon- optimiertem il-15 und verwendungsverfahren dafür
AU2014306271A1 (en) 2013-08-08 2016-03-24 The Scripps Research Institute A method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1289A1 (fr) * 1978-10-13 1980-07-22 Hoffmann La Roche Phenyl quinolizidines
EP0067565A1 (en) * 1981-06-16 1982-12-22 Beecham Group Plc Pharmaceutically active compounds
GB8408292D0 (en) * 1984-03-30 1984-05-10 Fujisawa Pharmaceutical Co Quinolizinone compound
GB8420602D0 (en) * 1984-08-14 1984-09-19 Wyeth John & Brother Ltd Thienoquinolizines
NO162285C (no) * 1984-11-23 1989-12-06 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
GB8509435D0 (en) * 1985-04-12 1985-05-15 Beecham Group Plc Intermediates & process
AU582663B2 (en) * 1985-08-10 1989-04-06 John Wyeth & Brother Limited Sulphonamides
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines

Also Published As

Publication number Publication date
IE58850B1 (en) 1993-11-17
ES554427A0 (es) 1987-12-01
DE3576691D1 (de) 1990-04-26
HUT38638A (en) 1986-06-30
AU584132B2 (en) 1989-05-18
EP0318682B1 (de) 1993-03-31
NO854404L (no) 1986-05-07
ZW17385A1 (en) 1986-02-19
JPH0692405B2 (ja) 1994-11-16
ES8800939A1 (es) 1987-12-01
ES554430A0 (es) 1987-12-01
IL76894A (en) 1989-06-30
ES8705436A1 (es) 1987-05-01
DK507685A (da) 1986-05-07
DOP1985004378A (es) 1991-04-05
ES554432A0 (es) 1987-12-01
FI89049B (fi) 1993-04-30
JPS61115082A (ja) 1986-06-02
NO171914C (no) 1993-05-19
AU4924185A (en) 1986-05-15
CA1277659C (en) 1990-12-11
PT81431B (pt) 1988-03-03
PT81431A (en) 1985-12-01
ES554429A0 (es) 1987-12-01
ES554431A0 (es) 1987-12-01
GB2169288A (en) 1986-07-09
AR242579A1 (es) 1993-04-30
US5036066A (en) 1991-07-30
ATE51232T1 (de) 1990-04-15
DE3587235D1 (en) 1993-05-06
ES8800933A1 (es) 1987-12-01
FI89049C (fi) 1993-08-10
EP0183994A1 (de) 1986-06-11
ES8800937A1 (es) 1987-12-01
ES8800934A1 (es) 1987-12-01
CN1016871B (zh) 1992-06-03
GB8527196D0 (en) 1985-12-11
IL76894A0 (en) 1986-02-28
FI854211A0 (fi) 1985-10-28
IE852751L (en) 1986-05-06
ES548532A0 (es) 1987-05-01
NO171914B (no) 1993-02-08
GB2169288B (en) 1989-06-01
IS3054A7 (is) 1986-05-07
ES8800932A1 (es) 1987-12-01
IS1469B6 (is) 1991-09-24
EP0183994B1 (de) 1990-03-21
DK507685D0 (da) 1985-11-04
EP0318682A2 (de) 1989-06-07
MC1707A1 (fr) 1986-09-22
HU205353B (en) 1992-04-28
MY103172A (en) 1993-05-29
ES8800935A1 (es) 1987-12-01
US4735940A (en) 1988-04-05
CN85108120A (zh) 1986-11-05
ES554426A0 (es) 1987-12-01
EP0318682A3 (en) 1989-08-16
ES554428A0 (es) 1987-12-01

Similar Documents

Publication Publication Date Title
ES476305A1 (es) Un procedimiento para la preparacion de nuevos derivados aminicos
KR860004060A (ko) 티에닐 축합 피라졸 유도체의 제조방법
ES8802517A1 (es) Un procedimiento para preparar fenoxialquil (substituido con heterocido)-isoxazoles y furanos.
ATE68473T1 (de) 1-phenyl-3-naphthalenyloxy-propanamine.
ATE73791T1 (de) Benzopyran-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
CO4700452A1 (es) Derivados de indol
ES534505A0 (es) Un procedimiento para la preparacion de compuestos de 1, 4-dihidropiridina
ES8800937A1 (es) Un procedimiento para la obtencion de derivados de bi- y triciclicos de piridona
ATE69222T1 (de) 2-amino-oxazoline und verfahren zu ihrer herstellung.
KR920004394A (ko) 티에노디아제핀 이의 제조방법 및 paf-길항 활성을 지닌 약제학적 조성물로서의 이의 용도
ZA826891B (en) Triazoloquinazolone derivatives
ES2262504T3 (es) Derivados del acido piroglutamico y compuestos afines que inhiben la adhesion de leucocitos mediada por la vla-4.
FR2449677B1 (fr) Nouveaux derives de benzoyl-2 glycylanilides substitues, leur preparation et leur application en tant que medicaments anxiolytiques
ATE140229T1 (de) Benzoxazepinon-verfahren
ATE88467T1 (de) Pharmakologisch aktive alkylol-derivate.
FR2479219B1 (es)
IL94605A (en) Substituted aminoalkylbenzene derivatives, their manufacture and pharmaceutical compositions containing them
ES8800938A1 (es) Procedimiento para preparar derivados berbanicos biologicamente activos.
LT2199B (lt) 2-triazolidinono dariniu gavimo budas
IL89682A0 (en) 5,7-dihydropyrrolo(3,2-f)-benzoxazol-6-ones,processes for the preparation thereof and pharmaceutical compositions containing them
JPS5714590A (en) 2-benzyl-5-alkyl-tetrahydro-benzo(b)-1,6-naphthyridin-10-one derivative and its preparation
ES8802496A1 (es) Procedimiento para preparar dihidropiridinas
ES2058580T3 (es) Nuevos beta-d-feniltioxilosidos, su metodo de preparacion y su uso como medicamentos.
FI824479A0 (fi) Foerfarande och mellanprodukt foer framstaellning av farmakologiskt verksamma (1,2)-anellerade 1,4-bensodiazepinfoereningar
GB2014561A (en) Amine derivatives, their preparation and pharmaceutical compositions containing them